Farinati F - Search Results

1

Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety.

Vitale A, Volk ML, Pastorelli D, Lonardi S, Farinati F, Burra P, Angeli P, Cillo U. Vitale A, et al. Among authors: farinati f. Hepatology. 2010 Jan;51(1):165-73. doi: 10.1002/hep.23260. Hepatology. 2010. PMID: 19877181 Free article.

2

Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen.

Farinati F, Salvagnini M, de Maria N, Fornasiero A, Chiaramonte M, Rossaro L, Naccarato R. Farinati F, et al. J Hepatol. 1990 Nov;11(3):297-301. doi: 10.1016/0168-8278(90)90211-9. J Hepatol. 1990. PMID: 1705274 Clinical Trial.

3

[Peptic ulcer and liver cirrhosis. Clinico-epidemiologic considerations].

Burra P, Di Mario F, Gottardello L, Dalrì L, Salvagnini M, Battaglia G, Farinati F, Naccarato R. Burra P, et al. Among authors: farinati f. Minerva Med. 1990 Mar;81(3):119-28. Minerva Med. 1990. PMID: 2320279 Italian.

4

Hepatocellular carcinoma in primary biliary cirrhosis.

Farinati F, Floreani A, De Maria N, Fagiuoli S, Naccarato R, Chiaramonte M. Farinati F, et al. J Hepatol. 1994 Sep;21(3):315-6. doi: 10.1016/s0168-8278(05)80307-1. J Hepatol. 1994. PMID: 7530737

5

Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis.

Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R. Farinati F, et al. J Hepatol. 1995 Apr;22(4):449-56. doi: 10.1016/0168-8278(95)80108-1. J Hepatol. 1995. PMID: 7545199

6

Hepatic and extrahepatic malignancies in primary biliary cirrhosis.

Floreani A, Baragiotta A, Baldo V, Menegon T, Farinati F, Naccarato R. Floreani A, et al. Among authors: farinati f. Hepatology. 1999 May;29(5):1425-8. doi: 10.1002/hep.510290501. Hepatology. 1999. PMID: 10216125

7

Surveillance for hepatocellular carcinoma in cirrhosis: is it cost-effective?

Farinati F, Gianni S. Farinati F, et al. Eur J Cancer Prev. 2001 Feb;10(1):111-5. doi: 10.1097/00008469-200102000-00017. Eur J Cancer Prev. 2001. PMID: 11263586 No abstract available.

8

HBV and HCV infections in heart transplant recipients.

Fagiuoli S, Minniti F, Pevere S, Farinati F, Burra P, Livi U, Naccarato R, Chiaramonte M. Fagiuoli S, et al. Among authors: farinati f. J Heart Lung Transplant. 2001 Jul;20(7):718-24. doi: 10.1016/s1053-2498(01)00255-8. J Heart Lung Transplant. 2001. PMID: 11448796

9

Does the choice of treatment influence survival of patients with small hepatocellular carcinoma in compensated cirrhosis?

Farinati F, Gianni S, Marin G, Fagiuoli S, Rinaldi M, Naccarato R. Farinati F, et al. Eur J Gastroenterol Hepatol. 2001 Oct;13(10):1217-24. doi: 10.1097/00042737-200110000-00015. Eur J Gastroenterol Hepatol. 2001. PMID: 11711779

10

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma.

Cillo U, Vitale A, Bassanello M, Boccagni P, Brolese A, Zanus G, Burra P, Fagiuoli S, Farinati F, Rugge M, D'Amico DF. Cillo U, et al. Among authors: farinati f. Ann Surg. 2004 Feb;239(2):150-9. doi: 10.1097/01.sla.0000109146.72827.76. Ann Surg. 2004. PMID: 14745321 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

404 results

Search Page